Speakers 2025

Speakers 2021 2022 2023 2024 2025

Sylvain PERRUCHE

MED’INN’PHARMA

SCIENTIFIC COMMITEE


CELL-BASED AND CELL-DERIVED INNOVATIVE THERAPIES

PhD in Immunology and former director of the Autoimmunity-Transplantation-Inflammation research team at the INSERM-Univ Franche Comté-EFS Joint Research Unit 1098 RIGHT in Besançon (FR), Dr Perruche is also the founder and CEO of MED’INN’PHARMA biotech company. He is specialized in the development of innovative therapeutic approaches to control the immune system and in particular inflammation. After defending his thesis in 2005 on the use of apoptotic cell-based therapeutic products to modulate post-transplant alloreactivity, he lived in Washington, D.C. couple of years to perform a post-doctoral fellowship at the National Institutes of Health, Bethesda (MD, USA). Back in Besançon with a permanent position at the French National institute of Health and Medical Research, he further developed innovative approaches to control inflammation. Notably, he filed several patents for a secretome-based approaches to control long term inflammation and reengage resolution and tissue healing in the context of inflammatory and degenerative disorders. Very active in the field of Resolution pharmacology, he setup the Resolution Days seminar series in 2018, gathering stakeholders from research to translational medicine in the Resolution of inflammation, and the last 2025 edition was held gathered more than 120 Resolutionists in Frankfurt (DE).  

Find also